ES8502437A1 - Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol. - Google Patents

Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol.

Info

Publication number
ES8502437A1
ES8502437A1 ES516272A ES516272A ES8502437A1 ES 8502437 A1 ES8502437 A1 ES 8502437A1 ES 516272 A ES516272 A ES 516272A ES 516272 A ES516272 A ES 516272A ES 8502437 A1 ES8502437 A1 ES 8502437A1
Authority
ES
Spain
Prior art keywords
benzodioxin
formula
azapentane
diols
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES516272A
Other languages
English (en)
Other versions
ES516272A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES516272A0 publication Critical patent/ES516272A0/es
Publication of ES8502437A1 publication Critical patent/ES8502437A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DEL 1-(2,3-DIHIDRO-1,4-BENZODIOXIN-2S-IL)-5-(2,3-DIHIDRO-1,4-BENZODIOXIN-2R-IL)-3-AZAPENTAN1R-5S-DIOL.CONSISTE EN HIDROGENIZAR MEDIANTE TRATAMIENTO CON HIDROGENO CATALITICAMENTE ACTIVADO O NASCENTE, O GENERADO ELECTROLITICAMENTE, UN COMPUESTO DE FORMULA (II) O UNA MEZCLA DE ISOMEROS QUE CONTIENE UN COMPUESTO DE FORMULA (II), PARA OBTENER UN COMPUESTO DE FORMULA (I), DONDE Y SIGNIFICA UN RESTO BAB-ARAILFATICO O UN RESTO ACILO. SE PUEDE SEPARAR LA MEZCLA DE ISOMEROS OBTENIDA O TRANSFORMAR UN COMPUESTO LIBRE OBTENIDO EN UNA SAL DE ADICION DE ACIDO.
ES516272A 1980-10-14 1982-10-06 Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol. Expired ES8502437A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/196,503 US4313955A (en) 1980-10-14 1980-10-14 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols

Publications (2)

Publication Number Publication Date
ES516272A0 ES516272A0 (es) 1985-01-01
ES8502437A1 true ES8502437A1 (es) 1985-01-01

Family

ID=22725667

Family Applications (3)

Application Number Title Priority Date Filing Date
ES506212A Granted ES506212A0 (es) 1980-10-14 1981-10-13 Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-ben- zodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-aza-pentan-1r-5s-diol
ES516272A Expired ES8502437A1 (es) 1980-10-14 1982-10-06 Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol.
ES527677A Expired ES8600282A1 (es) 1980-10-14 1983-11-30 Procedimiento para la obtencion de 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro)1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES506212A Granted ES506212A0 (es) 1980-10-14 1981-10-13 Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-ben- zodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-aza-pentan-1r-5s-diol

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES527677A Expired ES8600282A1 (es) 1980-10-14 1983-11-30 Procedimiento para la obtencion de 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro)1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol

Country Status (21)

Country Link
US (1) US4313955A (es)
EP (1) EP0050585B1 (es)
JP (1) JPS5795982A (es)
KR (1) KR830007618A (es)
AR (1) AR227441A1 (es)
AT (1) ATE9694T1 (es)
AU (1) AU548164B2 (es)
DD (1) DD201678A5 (es)
DE (1) DE3166503D1 (es)
DK (1) DK454181A (es)
ES (3) ES506212A0 (es)
FI (1) FI813154A7 (es)
GB (1) GB2085008B (es)
GR (1) GR75089B (es)
HU (1) HU187378B (es)
IE (1) IE51645B1 (es)
IL (1) IL64033A (es)
NO (1) NO813446L (es)
NZ (1) NZ198619A (es)
PT (1) PT73812B (es)
ZA (1) ZA817048B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380653A (en) * 1980-10-14 1983-04-19 Ciba-Geigy Corporation 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
US4471128A (en) * 1981-09-08 1984-09-11 Ciba-Geigy Corporation 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
US4654362A (en) * 1983-12-05 1987-03-31 Janssen Pharmaceutica, N.V. Derivatives of 2,2'-iminobisethanol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038333A (en) * 1963-02-13 1966-08-10 Ici Ltd Pharmaceutical compositions
US4187313A (en) * 1978-01-30 1980-02-05 Ciba-Geigy Corporation 2-Aminoethyl-1,4-benzodioxans
US4261907A (en) * 1978-01-30 1981-04-14 Ciba-Geigy Corporation Stereospecific process
DE2827801A1 (de) * 1978-06-24 1980-01-10 Kali Chemie Pharma Gmbh Neue n tief 1 -benzoyl-n tief 2 -phenyl-1,3-diaminopropan-2-ole, verfahren zu deren herstellung und arzneimittel
US4212808A (en) * 1979-03-09 1980-07-15 Ciba-Geigy Corporation 2-Oxiranyl-1,4-benzodioxans

Also Published As

Publication number Publication date
FI813154L (fi) 1982-04-15
IL64033A (en) 1984-08-31
ES8303403A1 (es) 1983-02-01
GR75089B (es) 1984-07-13
AU548164B2 (en) 1985-11-28
IE812399L (en) 1982-04-14
DD201678A5 (de) 1983-08-03
AR227441A1 (es) 1982-10-29
JPS5795982A (en) 1982-06-15
IE51645B1 (en) 1987-01-21
DK454181A (da) 1982-04-15
EP0050585B1 (de) 1984-10-03
PT73812B (en) 1983-06-20
NO813446L (no) 1982-04-15
ATE9694T1 (de) 1984-10-15
HU187378B (en) 1985-12-28
ES527677A0 (es) 1985-10-01
KR830007618A (ko) 1983-11-04
ES506212A0 (es) 1983-02-01
US4313955A (en) 1982-02-02
EP0050585A1 (de) 1982-04-28
PT73812A (en) 1981-11-01
GB2085008B (en) 1984-04-18
GB2085008A (en) 1982-04-21
ES516272A0 (es) 1985-01-01
AU7629081A (en) 1982-04-22
ES8600282A1 (es) 1985-10-01
ZA817048B (en) 1982-09-29
FI813154A7 (fi) 1982-04-15
NZ198619A (en) 1985-07-31
DE3166503D1 (en) 1984-11-08
IL64033A0 (en) 1982-01-31

Similar Documents

Publication Publication Date Title
ES2181725T3 (es) Inhibidores de hiv proteasa.
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
DK339184D0 (da) Imidazoliumforbindelser, mellemprodukter hertil og fremgangsmaade til deres anvendelse
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
GR851572B (es)
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ES507810A0 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES8303404A1 (es) Procedimiento para preparar 3-amino-sidnoniminas sustituidas.
ES8301926A1 (es) Un procedimiento para la preparacion de un compuesto
ES481720A1 (es) Procedimiento para la obtencion de celulosa.
ES8502437A1 (es) Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol.
ES2052533T3 (es) Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus.
ES8301200A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
PT81576B (pt) Processo para a preparacao de derivados de mercaptano e de composicoes faramceuticas que os contem
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES8505332A1 (es) Procedimiento para la fabricacion de derivados del acido benzoico con actividad antimicrobiana
ES556437A0 (es) Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos.
ES8504793A1 (es) Un procedimiento para la preparacion de una quinazolina
AR220710A1 (es) Nuevos derivados de n-(2-oxoperhidro-3-furil)-anilidas del acido ciclopropanocarboxilico;composiciones fungicidas que contienen estos compuestos,y procedimientos para producirlos
ES8506756A1 (es) Procedimiento para preparar derivados de afidicolina.
PH20310A (en) Optically active isomers of trans-3-(2-chloro-2-(4-chloro-phenyl)-vinyl)-2,2-dimethyl-cyclopropane-1-carboxylic acid o(-cyano-4-fluoro-3-phenoxy-benzyl ester and their use as ectoparasiticides
ES2051839T3 (es) Un procedimiento para preparar tiadiazol-guanidinas.
FR2395985A1 (fr) Sels d'acide benzenetetrayltetrakis (carbonylimino)-tetraisophtalique, leur procede de preparation et leur utilisation therapeutique comme inhibiteurs du complement